Neurotripanosomiasis americana: aspectos clínicos de un problema básico.

Neurotripanosomiasis americana: aspectos clínicos de un problema básico.

Trypanosoma cruzi es el agente causal de la enfermedad de Chagas, patología que afecta principalmente estructuras cardiacas e intestinales. Sin embargo, las complicaciones neurológicas no han sido adecuadamente identificadas y estudiadas en Colombia, a pesar de existir allí áreas geográficas que pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fidias E. León Sarmiento, Diddier G. Prada, Jaime Bayona Prieto, Vladimir Valderrama, Ingrid García, Marta E. León, Dan Sunnemark
Formato:	Artículo
Lenguaje:	English
Publicado:	Instituto Nacional de Salud 2003-12-01
Colección:	Biomédica: revista del Instituto Nacional de Salud
Materias:	trypanosoma cruzi neurotrypanosomiasis chagas? disease cerebrovascular disease neuromuscular diseases qualitative metaanalysis
Acceso en línea:	http://www.revistabiomedica.org/index.php/biomedica/article/view/1240

Ejemplares similares

Diagnóstico de tripanosomiasis americana en estudiantes de la Escuela Latinoamericana de Medicina
por: Jorge Pável Delgado La O', et al.

Seroprevalence of Trypanosoma cruzi infection in blood donors in the extreme South of Brazil
por: Tanise Freitas Bianchi, et al.
Publicado: (2022-04-01)

Clinical endings of subjects with chronic infection by Trypanosoma cruzi treated or not with agents
por: Juan Carlos Villar
Publicado: (2002-12-01)

Chagas disease as an underrecognized cause of stroke: implications for public health
por: Jorge Vásconez-González, et al.
Publicado: (2024-11-01)

Chronic Heart Disease after Treatment of Oral Acute Chagas Disease
por: Andrei Fornanciari Antunes, et al.

Chagas, a lógica e a descoberta Chagas, the logic and the discovery
por: François Delaporte
Publicado: (1995-02-01)

Prevalência de triatomíneos (Hemíptera: Reduviidae: Triatominae) infectados por Trypanosoma cruzi: sazonalidade e distribuição na região Ciénega do Estado de Jalisco, México Prevalence of triatomines (Hemíptera: Reduviidae: Triatominae) infected by Trypanosoma cruzi: seasonality and distribution in the Ciénega region of the State of Jalisco, Mexico
por: César Gómez-Hernández, et al.
Publicado: (2008-06-01)

Contribuciones de la genética y la proteómica al estudio de la enfermedad de Chagas Genomic and proteomic contributions for Chagas disease control
por: Teresa López-Ordóñez, et al.
Publicado: (2009-01-01)

Effects of severe protein restriction in levels of parasitemia and in mortality of mice accutely infected with Trypanosoma cruzi
por: Nildete G.L. Gomes, et al.
Publicado: (1994-03-01)

Xenodiagnóstico artificial "post-mortem" em chagásicos crônicos
por: Edison Reis Lopes, et al.
Publicado: (1986-12-01)

Detection of Trypanosoma cruzi in white-eared opossums (Didelphis albiventris) from Canoinhas, Santa Catarina State, Brazil
por: Giane Helenita Pontarolo, et al.
Publicado: (2025-02-01)

ANTI-Trypanosoma cruzi ANTIBODIES IN THE INHABITANTS OF URBAN AND RURAL AREAS OF ABADIA DOS DOURADOS, STATE OF MINAS GERAIS, BRAZIL
por: Eleuza Rodrigues MACHADO, et al.
Publicado: (1998-09-01)

Xenodiagnosis
por: Hugo Schenone
Publicado: (1999-09-01)

Why studies on invasion of host cell by Trypanosoma cruzi using stablished cell lines or primary cell cultures give conflicting results?
por: Barbosa Helene S
Publicado: (1999-01-01)

Reaching for the Holy Grail: insights from infection/cure models on the prospects for vaccines for Trypanosoma cruzi infection
por: Juan Bustamante, et al.
Publicado: (2015-05-01)

The role of the immune response on the development of severe clinical forms of human Chagas disease
por: Rodrigo Corrêa-Oliveira, et al.
Publicado: (1999-09-01)

An experimental and clinical assay with ketoconazole in the treatment of Chagas disease
por: Zigman Brener, et al.
Publicado: (1993-03-01)

Trypanosoma cruzi mucins: potential functions of a complex structure
por: Igor C Almeida, et al.
Publicado: (1999-09-01)

Why studies on invasion of host cell by Trypanosoma cruzi using stablished cell lines or primary cell cultures give conflicting results?
por: Helene S Barbosa
Publicado: (1999-09-01)

Inter-relation of sylvatic and domestic transmission of Trypanosoma cruzi in areas with and without domestic vectorial transmission in Minas Gerais, Brazil
por: L. Diotaiuti, et al.
Publicado: (1995-08-01)

Parasitological cure of Chagas disease: is it possible? Is it relevant?
por: Julio A Urbina
Publicado: (1999-09-01)

Progress towards interruption of transmission of Chagas disease
por: Alvaro Moncayo
Publicado: (1999-09-01)

Parasitological cure of Chagas disease: is it possible? Is it relevant?
por: Urbina Julio A
Publicado: (1999-01-01)

Trypanosoma cruzi seroprevalence and associated risk factors in cancer patients from Southern Brazil
por: Luciane d'Avila Rosenthal, et al.

Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection
por: Beatriz Basso, et al.
Publicado: (2008-06-01)

Deriving a parsimonious cardiac endpoint for use in epidemiological studies of Chagas disease: results from the Retrovirus Epidemiology Donor Study-II (REDS-II) cohort
por: Lewis F. Buss, et al.
Publicado: (2021-04-01)

Chagas disease in the United States: a call for increased investment and collaborative research
por: Nelson Iván Agudelo Higuita, et al.
Publicado: (2024-06-01)

Chagas disease in the 21st Century: a public health success or an emerging threat?
por: Bonney Kevin M.
Publicado: (2014-01-01)

Transmissão da doença de Chagas por transplante renal: ocorrência da forma aguda da doença em dois receptores de um mesmo doador Transmission of Chagas' disease through transplantede kidney: occurrence of the acute form of the disease in two recipients from the same donor
por: A.S. Ferraz, et al.
Publicado: (1993-10-01)

Chagas Disease: From Discovery to a Worldwide Health Problem
por: Kárita Cláudia Freitas Lidani, et al.
Publicado: (2019-07-01)

Aspectos clínico-laboratoriais da infecção natural por Trypanosoma cruzi em cães de Mato Grosso do Sul Clinical and laboratorial features of naturally occurring Trypanosoma cruzi infection in dogs from Mato Grosso do Sul
por: Alda Izabel de Souza, et al.
Publicado: (2008-08-01)

Seropositivity for anti-Trypanosoma cruzi antibodies among blood donors of the "Hospital Universitário Regional do Norte do Paraná", Londrina, Brazil Soropositividade para anticorpos anti-Tiypanosoma cruzi em doadores de sangue do Hospital Universitário Regional do Norte do Paraná, Londrina, Brasil
por: Edna Maria Vissoci Reiche, et al.
Publicado: (1996-06-01)

Natural Trypanosoma cruzi infection in dogs of endemic areas of the Argentine Republic
por: Marta A. Lauricella, et al.
Publicado: (1989-04-01)

Amastigotes forms of Trypanosoma cruzi detected in a renal allograft
por: CARVALHO Maria Fernanda C., et al.
Publicado: (1997-01-01)

Evaluation of the ELISA-F29 test as an early marker of therapeutic efficacy in adults with chronic Chagas disease Avaliação do tratamento tripanossomicida em coorte de adultos chagásicos crônicos através de técnicas sorológicas convencionais e ELISA-F29
por: Diana Fabbro, et al.
Publicado: (2013-06-01)

Evaluation of the ELISA-F29 test as an early marker of therapeutic efficacy in adults with chronic Chagas disease
por: Diana Fabbro, et al.
Publicado: (2013-06-01)

Histological and histoquantitative study of the rat parotid gland after Trypanosoma cruzi infection
por: Silva R.C., et al.
Publicado: (2000-06-01)

Prophylactic and therapeutic DNA vaccines against Chagas disease
por: Minerva Arce-Fonseca, et al.
Publicado: (2015-02-01)

Microbiome Alterations Driven by Trypanosoma cruzi Infection in Two Disjunctive Murine Models
por: Sergio Castañeda, et al.
Publicado: (2023-06-01)

The benefits of using selenium in the treatment of Chagas disease: prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice
por: Andréa P de Souza, et al.
Publicado: (2010-09-01)